Reversible posterior leukoencephalopathy syndrome and bevacizumab in breast cancer

J Clin Oncol. 2012 Sep 10;30(26):e257-9. doi: 10.1200/JCO.2011.38.8942. Epub 2012 May 29.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Angiogenesis Inhibitors / adverse effects*
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Bevacizumab
  • Breast Neoplasms / drug therapy*
  • Female
  • Humans
  • Posterior Leukoencephalopathy Syndrome / chemically induced*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab